Skip to main content
Top
Published in: Seminars in Immunopathology 6/2014

01-11-2014 | INTRODUCTION

Editorial introduction for Seminars in Immunopathology special issue on “Immune modulation, properties and models of CMV”

Authors: Tal Goldberger, Ofer Mandelboim

Published in: Seminars in Immunopathology | Issue 6/2014

Login to get access

Excerpt

Human cytomegalovirus (HCMV) is a highly clinically relevant pathogen. It efficiently infects large proportion of the adult population around the world, and it establishes lifelong latency. In healthy adults, the virus usually does not cause serious or long-lasting injuries; however, in immunocompromised or immune-suppressed patients (like transplant recipients), infection with HCMV can cause serious illnesses and affect many organs. This is also true in cases of congenital infections. In order to introduce novel antiviral interventions and perhaps even therapeutic agents, a better understanding of the viral life cycle, its tropism, and the ways by which it escapes immune elimination is mandatory. In this special issue of Seminars in Immunopathology, we attempt to establish a multifaceted integrative view of the virus and discuss future implications of our current knowledge. …
Metadata
Title
Editorial introduction for Seminars in Immunopathology special issue on “Immune modulation, properties and models of CMV”
Authors
Tal Goldberger
Ofer Mandelboim
Publication date
01-11-2014
Publisher
Springer Berlin Heidelberg
Published in
Seminars in Immunopathology / Issue 6/2014
Print ISSN: 1863-2297
Electronic ISSN: 1863-2300
DOI
https://doi.org/10.1007/s00281-014-0450-8

Other articles of this Issue 6/2014

Seminars in Immunopathology 6/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.